These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 28302010)
1. Discovery of Hedgehog Antagonists for Cancer Therapy. Khatra H; Bose C; Sinha S Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. Peukert S; Miller-Moslin K ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564 [TBL] [Abstract][Full Text] [Related]
3. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity. Zhang H; Sun Z; Liu Z; Song C Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039 [TBL] [Abstract][Full Text] [Related]
4. Development of anticancer agents targeting the Hedgehog signaling. Zhang X; Tian Y; Yang Y; Hao J Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894 [TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present). Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165 [No Abstract] [Full Text] [Related]
6. Hedgehog Signaling: From Basic Biology to Cancer Therapy. Wu F; Zhang Y; Sun B; McMahon AP; Wang Y Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127 [TBL] [Abstract][Full Text] [Related]
7. Current trends in Hedgehog signaling pathway inhibition by small molecules. Ghirga F; Mori M; Infante P Bioorg Med Chem Lett; 2018 Oct; 28(19):3131-3140. PubMed ID: 30177379 [TBL] [Abstract][Full Text] [Related]
8. Strategies to target the Hedgehog signaling pathway for cancer therapy. Xin M; Ji X; De La Cruz LK; Thareja S; Wang B Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702 [TBL] [Abstract][Full Text] [Related]
9. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers. Li QR; Zhao H; Zhang XS; Lang H; Yu K Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201 [TBL] [Abstract][Full Text] [Related]
10. Design of Hedgehog pathway inhibitors for cancer treatment. Bariwal J; Kumar V; Dong Y; Mahato RI Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872 [TBL] [Abstract][Full Text] [Related]
11. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy. Tremblay MR; Nesler M; Weatherhead R; Castro AC Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype. Infante P; Alfonsi R; Ingallina C; Quaglio D; Ghirga F; D'Acquarica I; Bernardi F; Di Magno L; Canettieri G; Screpanti I; Gulino A; Botta B; Mori M; Di Marcotullio L Cell Death Dis; 2016 Sep; 7(9):e2376. PubMed ID: 27899820 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies. Banerjee U; Hadden MK Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423 [TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer. Yun JI; Kim HR; Park H; Kim SK; Lee J Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475 [TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer. Xie H; Paradise BD; Ma WW; Fernandez-Zapico ME Cells; 2019 Apr; 8(5):. PubMed ID: 31035664 [TBL] [Abstract][Full Text] [Related]
16. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors. Queiroz KC; Spek CA; Peppelenbosch MP Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179 [TBL] [Abstract][Full Text] [Related]
17. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Stanton BZ; Peng LF Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066 [TBL] [Abstract][Full Text] [Related]
18. Current Status of Hedgehog Signaling Inhibitors. Wang X; Wang T; Song X; Gao J; Xu G; Ma Y; Song G Curr Top Med Chem; 2024; 24(3):243-258. PubMed ID: 38231069 [TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling pathway and cancer therapeutics: progress to date. Ruch JM; Kim EJ Drugs; 2013 May; 73(7):613-23. PubMed ID: 23605693 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol. Wang F; Stappenbeck F; Matsui W; Parhami F J Cell Biochem; 2017 Mar; 118(3):499-509. PubMed ID: 27490478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]